Cost comparison between apixaban and low molecular weight heparin (LMWH) among venous thromboembolism (VTE) patients with cancer.
OBJECTIVE This study evaluated and compared healthcare costs associated with apixaban versus low molecular weight heparin (LMWH) treatment among cancer patients who have venous thromboembolism (VTE). METHODS A retrospective database analysis was conducted using IQVIA's PharMetrics Plus healthcare claims database, fro...